Key facts
- Samsung Electronics and SK hynix will build HBM fabs and packaging facilities.
- The facilities will be located in South Korea's Chungcheong region.
- The investment drive totals 392 trillion won.
- The initiative aims to bolster the nation's AI-led growth.
- South Korea's pharmaceutical exports surpassed $10 billion in 2025.
- This marks a record high for pharmaceutical exports.
- Production reached a new peak driven by biopharmaceuticals.
- Contract development capabilities also contributed to export growth.
South Korea is making substantial investments and achieving record growth in its advanced manufacturing and pharmaceutical sectors. Samsung Electronics and SK hynix are spearheading a significant investment drive, committing 392 trillion won to establish high bandwidth memory (HBM) fabrication and packaging facilities within the Chungcheong region. This strategic move is designed to enhance South Korea's capabilities in AI-driven industries and bolster its overall industrial prowess.
